by | May 2010
Abstract The stimulation of innovation in the pharmaceutical industry through outsourcing of research and development (R&D) activities within the drug discovery and development process is analyzed. The empirical data were collected through interviews with experts... by | May 2010
Abstract In this paper we discuss how companies in the Belgian food industry are affected by the REACH legislation and whether their competitiveness is weakened as a result. The study has been carried out through an extensive literature study, an electronic survey,... by | May 2010
Abstract Emerging regulatory initiatives in the EU are driving towards more environmentally safe chemicals, used as such or in a wide range of products and applications. The aim of the regulations is also to foster and support the emergence of new or safer... by | May 2010
Apredictionwasmade here in January 2009, that the market for company mergers and acquisitions in the pharmaceutical industry would continue to reach a high level in 2009, even after the announced cases of large M&As (e.g. Novartis/ Alcon, Roche/Genentech,... by | May 2010
Chemical and pharmaceutical companies are breathing a sigh of relief as the great crisis seems to be over. Customer industries, like automobile or construction, are sending slight signs of revitalization. Although recovery will be a long and slow process, more and...